Názor k článku Testování protilátek ohrožuje zisky z očkování od Peter Tuhársky - Pre začiatok, čierny kašeľ: Gustafsson L, Hallander HO, Olin...

Pre začiatok, čierny kašeľ:

Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996 Feb 8;334(6):349-55. PMID: 8538705.

Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med. 1996 Feb 8;334(6):341-8. PMID: 8538704.

Liese JG, Meschievitz CK, Harzer E, Froeschle J, Hosbach P, Hoppe JE, Porter F, Stojanov S, Niinivaara K, Walker AM, Belohradsky BH. Efficacy of a two-component acellular pertussis vaccine in infants. Pediatr Infect Dis J. 1997 Nov;16(11):1038-44. PMID: 9384336.

Trollfors B, Taranger J, Lagergard T, et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med. 1995 Oct 19;333(16):1045-50. PMID: 7675047.

Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 1998 Dec;16(20):1907-16. PMID: 9796042

Srugo I, Benilevi D, Madeb R, Shapiro S, Shohat T, Somekh E, Rimmar Y, Gershtein V, Gershtein R, Marva E, Lahat N. Pertussis infection in fully vaccinated children in day-care centers, Israel. Emerg Infect Dis. 2000 Sep-Oct;6(5):526-9. PMID: 10998384. PMCID: PMC2627963.

Podrobné vyhodnotenie s ďalšími odkazmi: http://rizikaockovania.sk/dok/Kolektivna_imunita-myty_a_fakty.pdf

Hepatitída B:

Street AC, Weddle TZ, Thomann WR, Lundberg EW, Jackson GW, Hamilton JD. Persistence of antibody in healthcare workers vaccinated against hepatitis B. Infect Control Hosp Epidemiol. 1990 Oct;11(10):525-30. PMID:2146315.

Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, Hall A. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ. 2002 Sep 14;325(7364):569. PMID:12228132. PMCID:PMC124550.